• 51 Hits
  • Search Condition : Filter (MeSH = CD8-Positive T-Lymphocytes / immunology)
Species Resource Title
Human and Animal Cells RAW 264(RCB0535) Sustained inhibition of CSF1R signaling augments antitumor immunity through inhibiting tumor-associated macrophages.
Human and Animal Cells ATN-1(RCB1440) Antitumor immunostimulatory effect via cell-killing action of a novel extracorporeal blood circulating photodynamic therapy system using 5-aminolevulinic acid.
Human and Animal Cells Vero(RCB0001) STING activator 2'3'-cGAMP enhanced HSV-1-based oncolytic viral therapy.
Human and Animal Cells , DNA material ACC-MESO-1(RCB2292) , ACC-MESO-4(RCB2293) , HMMME(RCB0819) , Human HLA-A*24:02:01 cDNA (RDB02871) Enhancing the immunogenicity of Wilms tumor 1 epitope in mesothelioma cells with immunoproteasome inhibitors.
Human and Animal Cells HSC-2(RCB1945) , HSC-3(RCB1975) , HSC-4(RCB1902) , Ca9-22(RCB1976) PAK4 inhibition augments anti-tumour effect by immunomodulation in oral squamous cell carcinoma.
Human and Animal Cells LM8(RCB1450) Enhancement of antitumor immunity by combining anti-cytotoxic T lymphocyte antigen-4 antibodies and cryotreated tumor lysate-pulsed dendritic cells in murine osteosarcoma.
Human and Animal Cells LM8(RCB1450) Anti-TGF-β antibody combined with dendritic cells produce antitumor effects in osteosarcoma.
Human and Animal Cells B16 Induction of antigen-specific immune responses against malignant brain tumors by intramuscular injection of sindbis DNA encoding gp100 and IL-18.
Human and Animal Cells 293T(RCB2202) Blocking PD-L1-PD-1 improves senescence surveillance and ageing phenotypes.
Human and Animal Cells B16F10(RCB2630) Intratumoral CD4+ T lymphodepletion sensitizes poorly immunogenic melanomas to immunotherapy with an OX40 agonist.
Human and Animal Cells OP9(RCB1124) , OP9/G-DLL1(RCB2925) In situ delivery of iPSC-derived dendritic cells with local radiotherapy generates systemic antitumor immunity and potentiates PD-L1 blockade in preclinical poorly immunogenic tumor models.
Human and Animal Cells YAC-1(RCB1165) Antitumor effect of immunizations with fusions of dendritic and glioma cells in a mouse brain tumor model.
Human and Animal Cells OS-RC-2(RCB0735) Nanoparticle-Mediated Delivery of 2-Deoxy-D-Glucose Induces Antitumor Immunity and Cytotoxicity in Liver Tumors in Mice.
Human and Animal Cells SKW-3(RCB1168) Identification of TCR repertoires in functionally competent cytotoxic T cells cross-reactive to SARS-CoV-2.
Human and Animal Cells PC-9(RCB4455) , RERF-LC-AI(RCB0444) 11β hydroxysteroid dehydrogenase 1: a new marker for predicting response to immune-checkpoint blockade therapy in non-small-cell lung carcinoma.
Human and Animal Cells iPS-MEF-Ng-20D-17(APS0001) Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice.
Human and Animal Cells TE-1(RCB1894) Prognostic Significance of PD-1, PD-L1 and CD8 Gene Expression Levels in Gastric Cancer.
Human and Animal Cells LAG(RCB2758) , LM8(RCB1450) , NFSa Y83(RCB0282) , KUM5(RCB2322) CSF1/CSF1R Signaling Inhibitor Pexidartinib (PLX3397) Reprograms Tumor-Associated Macrophages and Stimulates T-cell Infiltration in the Sarcoma Microenvironment.
Human and Animal Cells B16F10(RCB2630) Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells.
Human and Animal Cells LM8(RCB1450) Intravenous administration of the selective toll-like receptor 7 agonist DSR-29133 leads to anti-tumor efficacy in murine solid tumor models which can be potentiated by combination with fractionated radiotherapy.